Medicine and Dentistry
Malignant Neoplasm
94%
Therapeutic Procedure
58%
Patient
56%
Mechanism of Action
54%
Protein
47%
Immunoglobulin E Antibody
47%
Stimulus
47%
Cytotoxic T-Cell
47%
Basophil Cell
47%
Nodular Melanoma
47%
Immunoglobulin E
43%
Antibody
32%
Neoplasm
25%
Ex Vivo
19%
Therapeutic Agent
19%
Immune Checkpoint Inhibitor
18%
Monotherapy
18%
Immunotherapy
18%
Immune Response
17%
Hypersensitivity
15%
In Vitro
15%
Allergic Response
11%
Adverse Event
9%
Ipilimumab
9%
T Cell
9%
Pembrolizumab
9%
Monoclonal Antibody
9%
Experience
9%
Programmed Death 1 Receptor
9%
Cancer Treatment
7%
Solid Malignant Neoplasm
7%
Ovarian Cancer
7%
Paclitaxel
7%
Glycosylation
7%
Allergic Disease
7%
Clotiazepam
7%
Antineoplastic Activity
7%
Stimulation
7%
Antiparasitic Agent
7%
Immunology and Microbiology
Immunity
100%
Immunoglobulin E Antibody
94%
Immunoglobulin E
78%
Basophil Granulocyte
52%
Chondroitin Sulfate Proteoglycan
47%
Cytotoxic T Cell
47%
Melanoma Antigen
47%
Immunotherapy
30%
Monospecific Antibody
25%
Electric Potential
21%
Immune Response
17%
Hypersensitivity
15%
Type I Hypersensitivity
15%
Antineoplastic Activity
13%
Xenograft
11%
Hypersensitive Response
11%
Macrophage
11%
Basophil Activation
11%
Monocyte
11%
Gene
9%
Survival
9%
Monoclonal Antibodies
9%
Pembrolizumab
9%
Molecule
9%
Ipilimumab
9%
Nivolumab
9%
Experience
9%
Programmed Death 1 Receptor
9%
Solid
7%
CD63
7%
Glycosylation
7%
Development
7%
Therapeutic Antibodies
7%
Phenotype
5%
Mouse
5%
Antibody-Dependent Cell-Mediated Cytotoxicity
5%
Monoclonals
5%
Signal Transduction
5%
Tissues
5%
Immunocompetent Cell
5%
Prevalence
5%
Effector Cell
5%
Fc Receptor
5%
Biochemistry, Genetics and Molecular Biology
Antibody
94%
Melanoma-Associated Antigen
47%
Immunoglobulin E
47%
Chondroitin Sulfate Proteoglycan
47%
Immunoglobulin E
47%
Clinical Trial
15%
Antineoplastic Activity
13%
Monocyte
11%
Macrophage
11%
Development
7%
In Vitro Study
7%
Electric Potential
7%
Glycosylation
7%
Immune Response
7%
Solid
7%
Animal Models
7%
Therapeutic Antibodies
7%
Fc Receptor
5%
Antibody Dependent Cellular Cytotoxicity
5%
Immunocompetent Cell
5%
Phenotype
5%
Survival
5%
Signal Transduction
5%
Gene Signature
5%
Mouse
5%
Prevalence
5%